Vanguard Personalized Indexing Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$357K	Sell	19,880 -4,192	-17%	-$64.8K	﹤0.01%	1593
2026 Q1	$335K	Buy	24,072 +3,232	+16%	+$45.5K	﹤0.01%	1546
2025 Q4	$252K	Sell	20,840 -261	-1%	-$3.54K	﹤0.01%	1609
2025 Q3	$287K	Sell	21,101 -22	-0.1%	-$207	﹤0.01%	1530
2025 Q2	$135K	Sell	21,123 -633	-3%	-$3.08K	﹤0.01%	1692
2025 Q1	$77K	Buy	21,756 +4,032	+23%	+$14.3K	﹤0.01%	1646
2024 Q4	$67K	Buy	17,724 +1,132	+7%	+$5.33K	﹤0.01%	1664
2024 Q3	$53.8K	Buy	16,592 +4,851	+41%	+$10.9K	﹤0.01%	1671
2024 Q2	$22.3K	Buy	+11,741	New	+$22.8K	﹤0.01%	1642

Other funds holding AMLX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Personalized Indexing Management's AMLX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Amylyx Pharmaceuticals (AMLX) stake by 17% in Q2 2026, selling an estimated $64.8K and leaving 19,880 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #1593.

Vanguard Personalized Indexing Management first reported a position in AMLX in Q2 2024 and has held it in 9 quarters since. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

Vanguard Personalized Indexing Management held 19,880 shares of Amylyx Pharmaceuticals worth $357K as of Q2 2026.
Vanguard Personalized Indexing Management sold 4,192 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $64.8K.
Amylyx Pharmaceuticals made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1593 holding.
Vanguard Personalized Indexing Management first reported a position in Amylyx Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.